CVRx Inc (CVRX)

CVRx Inc (CVRX) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $36M; returns 1 day +3.6%, 1 week +9.2%, 1 year -85.9%.

CVRx, Inc. is a commercial-stage medical device company specializing in minimally invasive neuromodulation solutions for cardiovascular diseases. Their flagship product, Barostim Neo, is an implantable device designed to treat resistant hypertension and heart failure by stimulating baroreceptors in the carotid arteries.

Groups CVRX belongs to

CVRX financial model: income statement, cash flow and balance sheet